Vivos' cost-cutting initiatives also led to a $1 million or 27% year-over-year reduction in operating loss, versus the third quarter of 2023. For the nine months ended September 30, 2024 operating ...

Earlier this year, tirzepatide produced positive phase 3 results in treating sleep apnea and in reducing the risk of type ...

Dr. Amber Wheeler discusses the beauty breathing technique that could be the solution to snoring and other breathing abnormalities during sleep.